MetaCap

Arrowhead Pharmaceuticals (ARWR) News

NASDAQ: ARWRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.37-2.28 (-5.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ARWR news summary

We found 12 recent headlines mentioning Arrowhead Pharmaceuticals (ARWR): 0 in the past week and 9 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. ARWR is making an outsized move today, down 5.22% at $41.37, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Arrowhead Pharmaceuticals, Inc. Reports Fiscal 2026 Results and Announces $400 million Refinancing", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Arrowhead Pharmaceuticals headlines

Stocks mentioned alongside ARWR

Compare ARWR